688046.SHG Gempharmatech Co. Ltd. A

Healthcare Biotechnology Shanghai Stock Exchange
30.63 CNY
Close of Nov 4, 2026
12.69 43.28
Market cap
CNY 12.6B
P/E
54.7x
P/B
4.91x
ROE
9.8%
Dividend yield
0.49%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688046.SHG undervalued?

Graham number

The Graham number of Gempharmatech Co. Ltd. A cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Gempharmatech Co. Ltd. A fundamental analysis

No fundamental analysis for Gempharmatech Co. Ltd. A yet.

Gempharmatech Co. Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Gempharmatech Co. Ltd. A

GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, knock-in mouse, point-mutation mouse, transgenic mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testin…

Full company profile